Catherine Skari
-
Oct- 2022 -27 OctoberNews
NEW | Bluebirdbio Releases Resources For Patients On Gene Therapy Zynteglo®
To help people who are living with or caring for someone who has β-thalassaemia major get substantial information about Zynteglo®,…
Read More » -
27 OctoberNews
UNITED Onlus | The Italian Federation Of Thalassaemia Welcomes Newly Elected BoD
The assembly was held in the conference room of the Zone Hotel in Rome. The members of the new board…
Read More » -
18 OctoberNews
OUT NOW | 2021 TIF Annual Report Has Been Published
The 2021 Annual Report will cover the following and more: Message by TIF’s President and Executive Director 2021 in Numbers…
Read More » -
13 OctoberNews
THALASSAEMIA AND SICKLE CELL AUSTRALIA (TASCA) | Spring Newsletter 2022
Contents: Chair’s address Staff update TIF update TASCA Engagement In Memory of Lou Alborea TASCA kids’ page View the Newsletter…
Read More » -
Sep- 2022 -28 SeptemberNews
ADVANCED THERAPIES | Vertex, CRISPR To Submit Exa-Cel to FDA For β-Thalassaemia And Sickle Cell Disease
Vertex will submit its biologics licensing application (BLA) for exa-cel for rolling review, beginning in November 2022 and expects to…
Read More » -
22 SeptemberClinical News
CDC | Many Children With Sickle Cell Anaemia In The US Not Receiving Lifesaving Screening And Treatment
According to a recent CDC study, fewer than half children with the disease in the US get the necessary screening,…
Read More » -
19 SeptemberNews
CLINICAL NEWS | PYRUKYND® Receives Positive CHMP Opinion For The Treatment of PKD in Adults
PYRUKYND® is a first-in-class, oral PK activator that was recently approved by the U.S. Food and Drug Administration (FDA). If approved by the…
Read More » -
15 SeptemberScientific Literature
Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia
Background: With optimum transfusion and chelation therapy, the survival of β-thalassemia patients and the incidence of various complications, including renal…
Read More » -
8 September
-
8 SeptemberClinical News
SAFER BLOOD | EU Patients Have Begun Receiving Transfusions With Hemanext ONE® RBC Processing & Storage System
Doctors have begun transfusing patients suffering from hematological malignancies using RBCs processed and stored with the Hemanext ONE® system, as part…
Read More »

